RedHill Biopharma (RDHL) EBT Margin (2012 - 2023)
RedHill Biopharma's (RDHL) quarterly EBT Margin came in at 3280.68% in Q2 2023, up 324467.0% year-on-year from N/an in Q2 2022, and up 1590.99% on a QoQ basis from 220.03% in Q1 2023.
RedHill Biopharma (RDHL) EBT Margin (2012 - 2023) Analysis & Trends
RedHill Biopharma (RDHL) has 12 years of EBT Margin data on file, last reported at 3280.68% in Q2 2023.
- On a quarterly basis, EBT Margin rose 324467.0% year-over-year to 3280.68% in Q2 2023; TTM through Jun 2023 was 111.91%, a 2279.0% increase from a year earlier, with the FY2025 full-year figure at 150.0%, down 4720.0% from the prior year.
- EBT Margin for Q2 2023 stood at 3280.68%, up from 220.03% in the prior quarter.
- Over the last five years, EBT Margin for RDHL reached as high as 3280.68% in Q2 2023 and fell as low as 606.91% in Q4 2021.
- Historically, EBT Margin has averaged 375.89% across 5 years, with a median of 80.68% in 2021.
- Across the five-year window, EBT Margin slumped 149215 bps in 2021 and soared 324467 bps in 2023, its largest moves.
- Year by year, EBT Margin stood at 744.47% in 2019, then sank by 86 bps to 101.64% in 2020, then slumped by 697 bps to 606.91% in 2021, then rose by 10 bps to 543.22% in 2022, then jumped by 704 bps to 3280.68% in 2023.
- Per Business Quant data, the three most recent EBT Margin figures were 3280.68% in Q2 2023, 220.03% in Q1 2023, and 543.22% in Q4 2022.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | 10.97% |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 33.51% |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | -41.57% |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | 40.73% |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | -7.05% |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | 30.30% |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | 6.35% |
| 10 | RedHill Biopharma | 640,064.98 | 640,064.98 | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2023 | 3,280.68% |
| Mar 31, 2023 | -220.03% |
| Dec 31, 2022 | -543.22% |
| Sep 30, 2022 | -122.41% |
| Jun 30, 2022 | 36.01% |
| Mar 31, 2022 | 97.15% |
| Dec 31, 2021 | -606.91% |
| Sep 30, 2021 | 62.05% |
| Jun 30, 2021 | 96.04% |
| Mar 31, 2021 | 65.33% |
| Dec 31, 2020 | 101.64% |
| Sep 30, 2020 | 49.10% |
| Jun 30, 2020 | 42.84% |
| Mar 31, 2020 | 1,557.48% |
| Dec 31, 2019 | 744.47% |
| Sep 30, 2019 | 729.48% |
| Jun 30, 2019 | 903.71% |
| Mar 31, 2019 | 492.57% |
| Dec 31, 2018 | 912.58% |
| Sep 30, 2018 | 425.61% |